Table 1 Distribution of C(−159)T CD14 genotypes in patients with non‐alcoholic steatohepatitis (NASH) and non‐alcoholic fatty liver (NAFL), and in controls.

CD14 genotype	Controls (n = 52)	NAFL (n = 7)	NASH* (n = 21)
C/C	15 (28.8%)	0	4 (19.0%)
C/T	25 (48.1%)	7 (100%)	5 (23.8%)
T/T	12 (23.1%)	0	12 (57.1%)

*Genotype frequency (3×3 contingency table): NASH versus controls χ² = 17.211, p<0.002.